JAMA announced on July 1, 2023, the appointment of Yulin Hswen, ScD, MPH, as an associate editor in artificial intelligence (AI) and medicine. Hswen joins the editorial board, where she will help guide the strategic direction for JAMA and the JAMA Network.
“I am thrilled to have been appointed as an associate editor for JAMA and the JAMA Network. Artificial intelligence is growing at an unprecedented rate, and this is an opportunity for integrating equity into the field,” said Hswen. “JAMA has taken a stand on addressing topics like social justice and health disparities, and I look forward to highlighting these issues in AI and medicine.”
Hswen is a Harvard-trained computational epidemiologist and assistant professor in the Department of Epidemiology and Biostatistics and the Bakar Computational Health Sciences Institute at UCSF, where she leads research on using artificial intelligence to uncover social patterns of disease and the transmission of information through social networks.
"We warmly congratulate Dr. Hswen on her new role with JAMA and the JAMA Network," said Mark Pletcher, MD, MPH, Interim Chair of the Department of Epidemiology and Biostatistics. "How artificial intelligence impacts health research and healthcare delivery will be an important focus of our department in the coming years. We applaud the JAMA Network for their foresight and for Dr. Hswen’s contributions in this space."
Hswen received her doctor of science degree from the Harvard T.H. Chan School of Public Health. She is a National Institute of Health-funded researcher who has been recognized by organizations such as the Robert Wood Johnson Foundation for her innovative and transformative scientific studies in health and racial equity. Her expertise will help provide JAMA and the JAMA Network with ongoing advice and guidance on strategic direction in AI and medicine.
“I look forward to applying my expertise in social transmission of information to help disseminate JAMA and JAMA Network findings,” said Hswen. “I hope to ensure that JAMA and the JAMA Network will be at the forefront of translating findings into real-world changes in clinical practice and across broader areas such as in public health and society.”